Comparison of Standard Dose vs Higher Dose Low Molecular Weight Heparin and Unfractionated Heparin for DVT Prophylaxis in COVID-19 Patients

Authors

Zachary Brown PharmD, Parkview HealthFollow
Munyaradzi Chakabva MD, Parkview HealthFollow
Tabinda Akhtar MD, Parkview HealthFollow
Sarah Polina PharmD, BCPS, Parkview HealthFollow
Michael Todt PharmD, BCCCP, Parkview HealthFollow
Mckenna Brauner NP, Parkview HealthFollow
Meghan McGuire NP, Parkview HealthFollow
Aws Polina MD

Abstract

2021 ASHP Midyear Clinical Meeting / Virtual / Poster # 1121810

Objective: To evaluate whether higher dose VTE prophylaxis results in a significant reduction in VTE events without significant increase in bleeding risk when compared to standard dose VTE prophylaxis in patients with COVID-19 infection

Document Type

Article

Publication Date

2021

Recommended Citation

Brown, Zachary PharmD; Chakabva, Munyaradzi MD; Akhtar, Tabinda MD; Polina, Sarah PharmD, BCPS; Todt, Michael PharmD, BCCCP; Brauner, Mckenna NP; McGuire, Meghan NP; and Polina, Aws MD, "Comparison of Standard Dose vs Higher Dose Low Molecular Weight Heparin and Unfractionated Heparin for DVT Prophylaxis in COVID-19 Patients" (2021). Parkview Pharmacy Department. 51.
https://researchrepository.parkviewhealth.org/pharma/51